VALIDITY OF PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM HEALTH ASSESSMENT QUESTIONNAIRE (PROMIS HAQ) FOR ASSESSING DISEASE ACTIVITY IN IRAQI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

Authors

  • Samer I. Mohammed Department of Clinical Pharmacy -College of pharmacy-Baghdad University

Keywords:

Rheumatoid arthritis, Disease activity, PROMIS HAQ

Abstract

Objective: Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease that affects all ethnic groups throughout the world. Biochemical and clinical data are required to evaluate the disease activity and responsiveness to treatment. Disease activity score of 28 joints (DAS28) and simplified disease activity index (SDAI) are common tools that used to assess disease activity, whereas the Patient Reported Outcome Measurement Information System health assessment questionnaire (PROMIS HAQ) and HAQDI is a useful tool to assess the extent of the patient's functional ability. This study aimed to evaluate the effectiveness of PROMIS HAQ score for monitoring disease activity and response to therapy in Iraqi patients with active rheumatoid arthritis.

Methods: A cross-sectional study was conducted in Baghdad Teaching Hospital, Rheumatology outpatient Unit from September 2012 to April. A total of 140 patients (40 males and 100 females) with active RA were involved in this study Disease activity was measured by DAS28 and the SDAI whereas functional status of the patients was measured using PROMIS HAQ score.

Results: There was a significant positive correlation of PROMIS HAQ score with clinical parameters like swelling joint count (SJC), tender joint count (TJC), visual analogue scale (VAS) and physician global assessment (EGA). Additionally PROMIS HAQ was significantly correlated with simplified disease activity index (SDAI). Furthermore it correlated with inflammatory marker CRP. Conclusion: PROMIS HAQ score is a valid and useful tool to monitor disease activity and response to treatment in Iraqi patients with highly active RA.

Conclusion: PROMIS HAQ score is a valid and useful tool to monitor disease activity and response to treatment in Iraqi patients with highly active RA.

Downloads

Download data is not yet available.

Author Biography

Samer I. Mohammed, Department of Clinical Pharmacy -College of pharmacy-Baghdad University

Assistant Lecturer

References

Christopher VT, Joan MB. Rheumatoid arthritis. In:Klippel JH, Stone JH, Crofford LJ, White PH, eds., Primer on rheumatic diseases, 13th ed., New York:USA, Springer science and business media 2008;114-42.

Majithia V, Geraci SA (2007). "Rheumatoid arthritis:diagnosis and management". Am J Med 120 (11):936-9.

Ernest Choy. Understanding the dynamics:pathways involved in the pathogenesis of rheumatoid arthritis. J Rheumatology 2012;51:v3_v11.

Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. J Arthritis Rheum 1995;38:44-8

Smolen JS, Breedveld FC, Schiff MH, Kalden JR, et al. A simplified disease activity index forrheumatoid arthritis for use in clinical practice. J Rheumatology 2003;42:244-57.

Alchy EM, Gorial FI, Majeed IA, Hussain SA. Validity of simplified disease activity index using CRP titer in comparison to disease activity score-28 joints in Iraqi patients with active Rheumatoid arthritis. J ExpIntegr Med 2012;2(3):231-6.

Bruce B, Fries JF. The Stanford health assessment questionnaire:a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78.

Farheen K, Agarwal SK. Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm 2011;17(9 Suppl B):S09-13.

Anirban G, Biswadip G, Shantashil P, SandipSaha, et al. Comparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern India. Indian J of Rheumatology 2011;6(3):116-22.

Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target:recommendations of an international task force. J Ann Rheum Dis 2010;69:631-7.

Roy Fleischmann. Don’t forget traditional DMARDs. J Rheumatology 2011;50:429-30.

James RO. Rheumatoid arthritis. In:Lee Goldman, and Andrew I. Schafer. Goldman's Cecil Medicine, 24th ed. Philadelphia, USA:Elsevier Saunders 2012;CH 272, 1681-89.

Young A, Dixey J, Cox N, Davies P, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). J Rheumatology (Oxford) 2000;39(6):603-11.

Al-Rawi ZS, Alazzawi AJ, Alajili FM, Alwakil R. Rheumatoid arthritis in population samples in Iraq. J Ann Rheum Dis 1978;37:73-5.

Mitchell K. shared care-the way forward for patient oriented follow up care in rheumatoid arthritis. J Rheumatology 2000;39:457-58.

Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. J Arthritis Rheum 1995;38:44-8.

Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. J Rheumatology 2003;42:244-57

National Committee for Clinical Laboratory Standards (NCCLS). Reference and Selected Procedure for the Erythrocyte Sedimentation Rate (ESR) Test;Approved Standard-Fourth Edition. NCCLS document H2-A4, Wayne, PA, USA 2000.

Mitra B, Panja M. High sensitive C-reactive protein:a novel biochemical markers and its role in coronary artery disease. J Assoc Physicians India 2005;53:25-32

So T, Lee SW, Croft M. Tumor necrosis factor/ tumor necrosis receptor family members that positively regulate immunity. Int J Hematol 2006;83(1):1-11

Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI):a review of their usefulness and validity in rheumatoid arthritis. J Clin Exp Rheumatol 2005;23(5 Suppl 39):S100-8.

Cella D, Yount S, Rothrock N, Gershon R, et al. The patient reported outcomes measurement information system (PROMIS):Progress of an NIH roadmap cooperative group during its first two years. J Medical Care 2007;45:S3-S11.

Ghosh A, Ghosh B, Pain S, Pande A, Saha S, Banerjee A, Biswas AB. Comparison between DAS28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern India. Indian J of Rheumatology 2011;30(6):116-22.

Altınkesen E, Gelecek N. Functional status and quality of life in patients with early and late stage rheumatoid arthritis. J Fizyoter Rehabil 2011;22(2):93-9.

Ehab Mudher Mikhael, FaiqIsho Gorial. Validity of Health Assessment Questionnaire Disability Index (HAQDI) for Assessing Disease Activity in Iraqi Patients with Active Rheumatoid Arthritis. American J of Medical and Biological Res 2013;1(4):91-4.

Fries JF, Ramey DR.The Health Assessment Questionnaire (HAQ) and the Improved HAQ. Stanford University School of Medicine Division of Immunology & Rheumatology (Revised June 2009).

R S Amos, T J Constable, R A Crockson, et al. Rheumatoid arthritis:relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. Br Med J 1977;1(6055):195–7.

Nader Rahnama, Vahid Mazloum. Effects of Strengthening and Aerobic Exercises on Pain Severity and Function in Patients with Knee Rheumatoid Arthritis. Int J Prev Med 2012;3(7):493-8.

Published

31-08-2014

How to Cite

Mohammed, S. I. “VALIDITY OF PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM HEALTH ASSESSMENT QUESTIONNAIRE (PROMIS HAQ) FOR ASSESSING DISEASE ACTIVITY IN IRAQI PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 8, Aug. 2014, pp. 332-4, https://innovareacademics.in/journals/index.php/ijpps/article/view/1681.

Issue

Section

Original Article(s)